---
title: Dr Creighton Heaukulani
permalink: /speakers/track-speakers/creighton-heaukulani/
description: ""
third_nav_title: Track Speakers
---
<div style="display: flex; flex-wrap: wrap;">
  <div style="flex-basis: 100%; max-width: 100%;">
    <img alt="track speakers 1" src="/images/SpeakersPhoto/creightonheaukulaniv0.png">
  </div>
		</div>
				
<b>Topic Title</b>

<p id="left">Day 2, 1.30PM | The HOPES Service: Using Digital Phenotyping for Personalised Therapeutics and Stepped-up Care (A collaboration between MOHT and IMH)</p>

<b>Profile</b>	

Dr Creighton Heaukulani leads the Digital Healthcare Applications team within the Data, Science, &amp; Technology Group. The group runs digital health innovation initiatives, most recently focusing on mental health and wellness and on the management of chronic diseases. A flagship project revolves around the upcoming HOPES clinical service at IMH , which uses digital phenotyping to empower patients with schizophrenia and depression in self-management and to tailor digital therapeutics. Other major efforts include supporting the mindline.sg and Letâ€™s Talk mental wellness initiatives with data analytics, the development of data intelligence products and features, and programme evaluation.

Dr Heaukulani specialises in machine learning and statistics; he holds a PhD in Machine Learning from the University of Cambridge, completed in 2015, where he focused on Bayesian modeling and inference. He has previous work experience in finance, where he helped to establish a machine learning specialist team within the Securities Division at Goldman Sachs. Dr Heaukulani also has current interests and training in molecular biology and genetic engineering; he is currently enrolled as a part-time masters student in Biotechnology at the National University of Singapore, conducting research in a cancer epigenomics laboratory.